117 related articles for article (PubMed ID: 32717360)
1. A multimodal treatment of carbon ions irradiation, miRNA-34 and mTOR inhibitor specifically control high-grade chondrosarcoma cancer stem cells.
Vares G; Ahire V; Sunada S; Ho Kim E; Sai S; Chevalier F; Romeo PH; Yamamoto T; Nakajima T; Saintigny Y
Radiother Oncol; 2020 Sep; 150():253-261. PubMed ID: 32717360
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-100 resensitizes resistant chondrosarcoma cells to cisplatin through direct targeting of mTOR.
Zhu Z; Wang CP; Zhang YF; Nie L
Asian Pac J Cancer Prev; 2014; 15(2):917-23. PubMed ID: 24568519
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Src by microRNA-23b increases the cisplatin sensitivity of chondrosarcoma cells.
Huang K; Chen J; Yang MS; Tang YJ; Pan F
Cancer Biomark; 2017; 18(3):231-239. PubMed ID: 28085008
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic regulation of embryonic stem cell marker miR302C in human chondrosarcoma as determinant of antiproliferative activity of proline-rich polypeptide 1.
Galoian K; Qureshi A; D'Ippolito G; Schiller PC; Molinari M; Johnstone AL; Brothers SP; Paz AC; Temple HT
Int J Oncol; 2015 Aug; 47(2):465-72. PubMed ID: 26094604
[TBL] [Abstract][Full Text] [Related]
5. Biological aspects of chondrosarcoma: Leaps and hurdles.
Mery B; Espenel S; Guy JB; Rancoule C; Vallard A; Aloy MT; Rodriguez-Lafrasse C; Magné N
Crit Rev Oncol Hematol; 2018 Jun; 126():32-36. PubMed ID: 29759564
[TBL] [Abstract][Full Text] [Related]
6. Synergistic anti-proliferative effects of mTOR and MEK inhibitors in high-grade chondrosarcoma cell line OUMS-27.
Fukumoto S; Kanbara K; Neo M
Acta Histochem; 2018 Feb; 120(2):142-150. PubMed ID: 29397960
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-494 inhibits cell proliferation and invasion of chondrosarcoma cells in vivo and in vitro by directly targeting SOX9.
Li J; Wang L; Liu Z; Zu C; Xing F; Yang P; Yang Y; Dang X; Wang K
Oncotarget; 2015 Sep; 6(28):26216-29. PubMed ID: 26317788
[TBL] [Abstract][Full Text] [Related]
8. Anti-miRNA Oligonucleotide Therapy for Chondrosarcoma.
Sun X; Chen Y; Yu H; Machan JT; Alladin A; Ramirez J; Taliano R; Hart J; Chen Q; Terek RM
Mol Cancer Ther; 2019 Nov; 18(11):2021-2029. PubMed ID: 31341031
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer.
Vilquin P; Donini CF; Villedieu M; Grisard E; Corbo L; Bachelot T; Vendrell JA; Cohen PA
Breast Cancer Res; 2015 Jan; 17(1):13. PubMed ID: 25633049
[TBL] [Abstract][Full Text] [Related]
10. Sphingosine-1-phosphate suppresses chondrosarcoma metastasis by upregulation of tissue inhibitor of metalloproteinase 3 through suppressing miR-101 expression.
Tsai CH; Yang DY; Lin CY; Chen TM; Tang CH; Huang YL
Mol Oncol; 2017 Oct; 11(10):1380-1398. PubMed ID: 28672103
[TBL] [Abstract][Full Text] [Related]
11. Regulation of onco and tumor suppressor MiRNAs by mTORC1 inhibitor PRP-1 in human chondrosarcoma.
Galoian KA; Guettouche T; Issac B; Qureshi A; Temple HT
Tumour Biol; 2014 Mar; 35(3):2335-41. PubMed ID: 24178909
[TBL] [Abstract][Full Text] [Related]
12. Arsenic trioxide inhibits growth of human chondrosarcoma cells through G2/M arrest and apoptosis as well as autophagy.
Jiao G; Ren T; Guo W; Ren C; Yang K
Tumour Biol; 2015 May; 36(5):3969-77. PubMed ID: 25577250
[TBL] [Abstract][Full Text] [Related]
13. miRNA-497 Negatively Regulates the Growth and Motility of Chondrosarcoma Cells by Targeting Cdc25A.
Lu Y; Li F; Xu T; Sun J
Oncol Res; 2016; 23(4):155-63. PubMed ID: 27053344
[TBL] [Abstract][Full Text] [Related]
14. High control rates of proton- and carbon-ion-beam treatment with intensity-modulated active raster scanning in 101 patients with skull base chondrosarcoma at the Heidelberg Ion Beam Therapy Center.
Mattke M; Vogt K; Bougatf N; Welzel T; Oelmann-Avendano J; Hauswald H; Jensen A; Ellerbrock M; Jäkel O; Haberer T; Herfarth K; Debus J; Uhl M
Cancer; 2018 May; 124(9):2036-2044. PubMed ID: 29469932
[TBL] [Abstract][Full Text] [Related]
15. Targeting of cell survival genes using small interfering RNAs (siRNAs) enhances radiosensitivity of Grade II chondrosarcoma cells.
Kim DW; Seo SW; Cho SK; Chang SS; Lee HW; Lee SE; Block JA; Hei TK; Lee FY
J Orthop Res; 2007 Jun; 25(6):820-8. PubMed ID: 17343283
[TBL] [Abstract][Full Text] [Related]
16. High control rate in patients with chondrosarcoma of the skull base after carbon ion therapy: first report of long-term results.
Uhl M; Mattke M; Welzel T; Oelmann J; Habl G; Jensen AD; Ellerbrock M; Haberer T; Herfarth KK; Debus J
Cancer; 2014 May; 120(10):1579-85. PubMed ID: 24500784
[TBL] [Abstract][Full Text] [Related]
17. The expression of miR-181a-5p and miR-371b-5p in chondrosarcoma.
Mutlu S; Mutlu H; Kirkbes S; Eroglu S; Kabukcuoglu YS; Kabukcuoglu F; Duymus TM; ISık M; Ulasli M
Eur Rev Med Pharmacol Sci; 2015 Jul; 19(13):2384-8. PubMed ID: 26214773
[TBL] [Abstract][Full Text] [Related]
18. CCL5 promotes vascular endothelial growth factor expression and induces angiogenesis by down-regulating miR-199a in human chondrosarcoma cells.
Liu GT; Huang YL; Tzeng HE; Tsai CH; Wang SW; Tang CH
Cancer Lett; 2015 Feb; 357(2):476-87. PubMed ID: 25444917
[TBL] [Abstract][Full Text] [Related]
19. Cytostatic effect of the hypothalamic cytokine PRP-1 is mediated by mTOR and cMyc inhibition in high grade chondrosarcoma.
Galoian K; Temple TH; Galoyan A
Neurochem Res; 2011 May; 36(5):812-8. PubMed ID: 21243426
[TBL] [Abstract][Full Text] [Related]
20. MiR-100 up-regulation enhanced cell autophagy and apoptosis induced by cisplatin in osteosarcoma by targeting mTOR.
Yu Z; Li N; Jiang K; Zhang N; Yao LL
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5867-5873. PubMed ID: 30280766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
